Retail prices for brand name prescription drugs widely used by older Americans rose by an average of 15.5% in 2015—almost 130 times faster than the 0.1% general inflation rate—according to a new AARP Public Policy Institute (PPI) report released today.
 |
| Click on image for an enlarged view |
AARP’s
Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006-2015, shows that the average annual cost for one brand name drug used on a chronic basis now exceeds $5,800. Five of the six drugs with the highest cumulative price increases over the study period were marketed by Valeant Pharmaceuticals. The retail price of Valeant's anti-anxiety drug, Ativan 1 mg tablets,
increased by 2,873% between 2006 and 2015.
 |
| Click on image for enlarged view. |
Which companies raised prices the most? Crooked Valeant, of course, tops the list. But can you guess who is #2, #3, etc? Click "Read more" for the answer.
Read more »
Reviewed by admin
on
December 14, 2016
Rating:
No comments: